These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25655200)

  • 1. A precisely substituted benzopyran targets androgen refractory prostate cancer cells through selective modulation of estrogen receptors.
    Kumar R; Verma V; Sharma V; Jain A; Singh V; Sarswat A; Maikhuri JP; Sharma VL; Gupta G
    Toxicol Appl Pharmacol; 2015 Mar; 283(3):187-97. PubMed ID: 25655200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms--action of two new agents.
    Kumar R; Verma V; Sarswat A; Maikhuri JP; Jain A; Jain RK; Sharma VL; Dalela D; Gupta G
    Invest New Drugs; 2012 Apr; 30(2):582-93. PubMed ID: 21181231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
    Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
    J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pomegranate extract demonstrate a selective estrogen receptor modulator profile in human tumor cell lines and in vivo models of estrogen deprivation.
    Sreeja S; Santhosh Kumar TR; Lakshmi BS; Sreeja S
    J Nutr Biochem; 2012 Jul; 23(7):725-32. PubMed ID: 21839626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulators of estrogen receptor inhibit proliferation and migration of prostate cancer cells.
    Piccolella M; Crippa V; Messi E; Tetel MJ; Poletti A
    Pharmacol Res; 2014 Jan; 79():13-20. PubMed ID: 24184124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
    Lau KM; LaSpina M; Long J; Ho SM
    Cancer Res; 2000 Jun; 60(12):3175-82. PubMed ID: 10866308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2,3-Diaryl-2H-1-benzopyran derivatives interfere with classical and non-classical estrogen receptor signaling pathways, inhibit Akt activation and induce apoptosis in human endometrial cancer cells.
    Fatima I; Chandra V; Saxena R; Manohar M; Sanghani Y; Hajela K; Negi MP; Sankhwar PL; Jain SK; Dwivedi A
    Mol Cell Endocrinol; 2012 Jan; 348(1):198-210. PubMed ID: 21878365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designed modulation of sex steroid signaling inhibits telomerase activity and proliferation of human prostate cancer cells.
    Verma V; Sharma V; Singh V; Sharma S; Bishnoi AK; Chandra V; Maikhuri JP; Dwivedi A; Kumar A; Gupta G
    Toxicol Appl Pharmacol; 2014 Oct; 280(2):323-34. PubMed ID: 25123791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 2: structure-activity relationship studies on the benzopyran scaffold.
    Richardson TI; Norman BH; Lugar CW; Jones SA; Wang Y; Durbin JD; Krishnan V; Dodge JA
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3570-4. PubMed ID: 17485205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The small heat shock protein B8 (HSPB8) modulates proliferation and migration of breast cancer cells.
    Piccolella M; Crippa V; Cristofani R; Rusmini P; Galbiati M; Cicardi ME; Meroni M; Ferri N; Morelli FF; Carra S; Messi E; Poletti A
    Oncotarget; 2017 Feb; 8(6):10400-10415. PubMed ID: 28060751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-proliferative effect of 2-[piperidinoethoxyphenyl]-3-[4-hydroxyphenyl]-2H-benzo(b) pyran is potentiated via induction of estrogen receptor beta and p21 in human endometrial adenocarcinoma cells.
    Fatima I; Saxena R; Kharkwal G; Hussain MK; Yadav N; Hajela K; Sankhwar PL; Dwivedi A
    J Steroid Biochem Mol Biol; 2013 Nov; 138():123-31. PubMed ID: 23688837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NJK14013, a novel synthetic estrogen receptor-α agonist, exhibits estrogen receptor-independent, tumor cell-specific cytotoxicity.
    Kim HI; Kim T; Kim JE; Lee J; Heo J; Lee NR; Kim NJ; Inn KS
    Int J Oncol; 2015 Jul; 47(1):280-6. PubMed ID: 25964080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational approaches of drug design for the development of selective estrogen receptor modulators (SERMs), implicated in breast cancer.
    Makar S; Saha T; Swetha R; Gutti G; Kumar A; Singh SK
    Bioorg Chem; 2020 Jan; 94():103380. PubMed ID: 31757413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of cyclopropyl analogues of stilbene with raloxifene side chain as subtype-selective ligands for estrogen receptor.
    Yeo HL; Song YS; Ryu JH; Kim HD
    Arch Pharm Res; 2013 Sep; 36(9):1096-103. PubMed ID: 23613312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of isoflavones on prostate cancer cells and PTEN gene.
    Cao F; Jin TY; Zhou YF
    Biomed Environ Sci; 2006 Feb; 19(1):35-41. PubMed ID: 16673816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular identification of potential selective estrogen receptor modulator (SERM) like properties of phytoestrogens in the human breast cancer cell line MCF-7.
    Diel P; Olff S; Schmidt S; Michna H
    Planta Med; 2001 Aug; 67(6):510-4. PubMed ID: 11509969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apigenin manipulates the ubiquitin-proteasome system to rescue estrogen receptor-β from degradation and induce apoptosis in prostate cancer cells.
    Singh V; Sharma V; Verma V; Pandey D; Yadav SK; Maikhuri JP; Gupta G
    Eur J Nutr; 2015 Dec; 54(8):1255-67. PubMed ID: 25408199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of epidermal growth factor receptor induced by estrogens and phytoestrogens promotes the differentiation of U2OS human osteosarcoma cells.
    Salvatori L; Caporuscio F; Coroniti G; Starace G; Frati L; Russo MA; Petrangeli E
    J Cell Physiol; 2009 Jul; 220(1):35-44. PubMed ID: 19347870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer.
    Setlur SR; Mertz KD; Hoshida Y; Demichelis F; Lupien M; Perner S; Sboner A; Pawitan Y; Andrén O; Johnson LA; Tang J; Adami HO; Calza S; Chinnaiyan AM; Rhodes D; Tomlins S; Fall K; Mucci LA; Kantoff PW; Stampfer MJ; Andersson SO; Varenhorst E; Johansson JE; Brown M; Golub TR; Rubin MA
    J Natl Cancer Inst; 2008 Jun; 100(11):815-25. PubMed ID: 18505969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.